GW Pharmaceutical Announces Positive Phase 3 Trials
GW Pharmaceuticals (GWPH) is currently up 100%+ following positive results from their Phase 3 trials for the treatment of Dravet syndrome, a highly treatment-resistant epileptic syndrome. This is the 1st of 2 Phase 3 trials being conducted by GW Pharmaceuticals for...
An Undervalued Cannabis Company?
Aphria is 1 of 21 licensed producers authorized under the Marihuana for Medical Purposes (MMPR) that is able to both cultivate & sell cannabis in Canada. The firm has ~42,000 square feet of greenhouse cultivation space situated in Leamington, Ontario. Aphria is...
GW Pharmaceutical’s Upcoming Catalysts
Its been a rough patch holding GW Pharmaceuticals (GWPH), or any biotech company for the last 7 months. Back in July 2015, the iShares NASDAQ Biotechnology Index (IBB), an ETF that holds a basket of all publicly traded biotech companies in the NASDAQ reached a high of...
The Best Way to Invest in the Cannabis Industry
According to New Frontier Financials, the cannabis market is expected to jump from $6.7 billion in 2016 to $22 billion by 2020. With all this expected growth, there is sure to be many thriving companies and others scratching their heads’ wondering how they didn’t...
Cannabis Big Data New Frontier Joins Forces with Private Equity Phyto Partners
Frontier Financial Group Inc., (dba New Frontier) the Cannabis BigData firm, and leading provider of actionable intelligence and authoritative analytics, has announced a partnership with Florida-based Phyto Partners. New Frontier and Phyto have strategically aligned...
Phyto Partners Launches New Web Site
Congratulations to the Phyto Partners team on their new website. The site features all of the latest bells and whistles of a modern web 3.0 responsive design. Company information along with news and lead generation all add to the functionality of a clean, professional...
Want to invest with us?
Find out how we are Capitalizing America’s Next Great Industry
